Improving the engraftment and integration of cell transplantation for cardiac regeneration.
作者信息
Tu Chengyi, Mezynski Racheal, Wu Joseph C
机构信息
Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA 94305, USA.
North Carolina State University, Raleigh, NC 27605, USA.
出版信息
Cardiovasc Res. 2020 Mar 1;116(3):473-475. doi: 10.1093/cvr/cvz237.
Abstract
摘要
相似文献
1
Improving the engraftment and integration of cell transplantation for cardiac regeneration.改善用于心脏再生的细胞移植的植入和整合。
Cardiovasc Res. 2020 Mar 1;116(3):473-475. doi: 10.1093/cvr/cvz237.
2
Paracrine Effects of the Pluripotent Stem Cell-Derived Cardiac Myocytes Salvage the Injured Myocardium.多能干细胞衍生的心肌细胞的旁分泌作用挽救受损心肌。
Circ Res. 2017 Sep 1;121(6):e22-e36. doi: 10.1161/CIRCRESAHA.117.310803. Epub 2017 Jul 25.
3
Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.近期干细胞研究进展：用于疾病建模的诱导多能干细胞及基于干细胞的再生
Circulation. 2010 Jul 6;122(1):80-7. doi: 10.1161/CIRCULATIONAHA.109.881433.
4
Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes?用人诱导多能干细胞进行安全有效的心脏再生治疗：我们应如何制备纯心肌细胞？
Circ Res. 2017 May 12;120(10):1558-1560. doi: 10.1161/CIRCRESAHA.116.310328.
5
Cardiac repair with pluripotent stem cell-derived cardiomyocytes: Proof of concept but new challenges.多能干细胞衍生心肌细胞用于心脏修复：概念验证但面临新挑战。
J Thorac Cardiovasc Surg. 2017 Sep;154(3):945-948. doi: 10.1016/j.jtcvs.2017.05.088. Epub 2017 Jun 3.
6
Mining Exosomal MicroRNAs from Human-Induced Pluripotent Stem Cells-Derived Cardiomyocytes for Cardiac Regeneration.从人诱导多能干细胞衍生的心肌细胞中挖掘外泌体微小RNA用于心脏再生
Methods Mol Biol. 2018;1733:127-136. doi: 10.1007/978-1-4939-7601-0_10.
7
Perspectives on stem cell therapy for cardiac regeneration. Advances and challenges.干细胞治疗心脏再生的观点。进展与挑战。
Circ J. 2012;76(6):1307-12. doi: 10.1253/circj.cj-11-1479. Epub 2012 May 19.
8
Induced Pluripotent Stem Cells 10 Years Later: For Cardiac Applications.诱导多能干细胞 10 年后：心脏应用。
Circ Res. 2017 Jun 9;120(12):1958-1968. doi: 10.1161/CIRCRESAHA.117.311080.
9
Endogenous cardiac stem cells.内源性心脏干细胞
Prog Cardiovasc Dis. 2007 Jul-Aug;50(1):31-48. doi: 10.1016/j.pcad.2007.03.005.
10
Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.干细胞技术在心脏再生中的应用：多能干细胞的承诺。
EBioMedicine. 2017 Feb;16:30-40. doi: 10.1016/j.ebiom.2017.01.029. Epub 2017 Jan 27.
引用本文的文献
1
PRMT1 inhibition enhances the cardioprotective effect of adipose-derived mesenchymal stem cells against myocardial infarction through RUNX1.蛋白精氨酸甲基转移酶1（PRMT1）抑制通过RUNX1增强脂肪来源间充质干细胞对心肌梗死的心脏保护作用。
Stem Cell Res Ther. 2025 Jun 3;16(1):279. doi: 10.1186/s13287-025-04409-z.
2
Biomimetic Vascularized iPSC-Hepatocyte Spheroids for Liver Regeneration.用于肝脏再生的仿生血管化诱导多能干细胞来源的肝细胞球体
Adv Sci (Weinh). 2025 Feb;12(6):e2405662. doi: 10.1002/advs.202405662. Epub 2024 Dec 24.
3
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction.基因修饰间充质基质细胞：一种细胞疗法，能在心肌梗死后提供更有效的修复。
Stem Cell Res Ther. 2024 Sep 27;15(1):323. doi: 10.1186/s13287-024-03942-7.
4
Nicorandil-Pretreated Mesenchymal Stem Cell-Derived Exosomes Facilitate Cardiac Repair After Myocardial Infarction via Promoting Macrophage M2 Polarization by Targeting miR-125a-5p/TRAF6/IRF5 Signaling Pathway.尼可地尔预处理的间充质干细胞来源的外泌体通过靶向miR-125a-5p/TRAF6/IRF5信号通路促进巨噬细胞M2极化，从而促进心肌梗死后的心脏修复。
Int J Nanomedicine. 2024 Feb 29;19:2005-2024. doi: 10.2147/IJN.S441307. eCollection 2024.
5
Histone demethylase KDM5 regulates cardiomyocyte maturation by promoting fatty acid oxidation, oxidative phosphorylation, and myofibrillar organization.组蛋白去甲基化酶 KDM5 通过促进脂肪酸氧化、氧化磷酸化和肌原纤维组织来调节心肌细胞成熟。
Cardiovasc Res. 2024 May 7;120(6):630-643. doi: 10.1093/cvr/cvae014.
6
An injectable conductive hydrogel with dual responsive release of rosmarinic acid improves cardiac function and promotes repair after myocardial infarction.一种具有迷迭香酸双重响应释放功能的可注射导电水凝胶可改善心脏功能并促进心肌梗死后的修复。
Bioact Mater. 2023 Jul 12;29:132-150. doi: 10.1016/j.bioactmat.2023.07.007. eCollection 2023 Nov.
7
Suppressing Mesenchymal Stromal Cell Ferroptosis Via Targeting a Metabolism-Epigenetics Axis Corrects their Poor Retention and Insufficient Healing Benefits in the Injured Liver Milieu.通过靶向代谢-表观遗传学轴抑制间充质基质细胞铁死亡可纠正其在受损肝脏微环境中的保留不良和愈合作用不足。
Adv Sci (Weinh). 2023 May;10(13):e2206439. doi: 10.1002/advs.202206439. Epub 2023 Feb 19.
8
Hypoxia-induced CCL2/CCR2 axis in adipose-derived stem cells (ADSCs) promotes angiogenesis by human dermal microvascular endothelial cells (HDMECs) in flap tissues.缺氧诱导脂肪干细胞（ADSCs）中的 CCL2/CCR2 轴通过皮瓣组织中的人真皮微血管内皮细胞（HDMECs）促进血管生成。
J Physiol Biochem. 2023 May;79(2):327-339. doi: 10.1007/s13105-023-00944-6. Epub 2023 Feb 14.
9
Mesenchymal Stromal Cells Overexpressing Farnesoid X Receptor Exert Cardioprotective Effects Against Acute Ischemic Heart Injury by Binding Endogenous Bile Acids.过表达法尼醇 X 受体的间充质基质细胞通过结合内源性胆汁酸发挥对急性缺血性心脏损伤的心脏保护作用。
Adv Sci (Weinh). 2022 Aug;9(24):e2200431. doi: 10.1002/advs.202200431. Epub 2022 Jul 3.
10
Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction.支链氨基酸过度积累限制了骨髓间充质干细胞在心肌梗死中的治疗效果。
Signal Transduct Target Ther. 2022 Jun 3;7(1):171. doi: 10.1038/s41392-022-00971-7.
本文引用的文献
1
N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts.N-钙黏蛋白过表达增强了人诱导多能干细胞衍生的心肌细胞在梗死小鼠心脏中的修复能力。
Cardiovasc Res. 2020 Mar 1;116(3):671-685. doi: 10.1093/cvr/cvz179.
2
Human embryonic stem cell-derived cardiomyocytes restore function in infarcted hearts of non-human primates.人类胚胎干细胞衍生的心肌细胞可恢复非人灵长类动物梗死心脏的功能。
Nat Biotechnol. 2018 Aug;36(7):597-605. doi: 10.1038/nbt.4162. Epub 2018 Jul 2.
3
Soluble E-cadherin promotes tumor angiogenesis and localizes to exosome surface.可溶性 E-钙黏蛋白促进肿瘤血管生成，并定位于外泌体表面。
Nat Commun. 2018 Jun 11;9(1):2270. doi: 10.1038/s41467-018-04695-7.
4
Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.在器官芯片模型中使用干细胞的进展、障碍和限制。
Adv Drug Deliv Rev. 2019 Feb 1;140:3-11. doi: 10.1016/j.addr.2018.06.001. Epub 2018 Jun 6.
5
Prolonged survival of transplanted stem cells after ischaemic injury via the slow release of pro-survival peptides from a collagen matrix.通过胶原蛋白基质缓慢释放促存活肽，使移植的干细胞在缺血性损伤后实现长期存活。
Nat Biomed Eng. 2018 Feb;2(2):104-113. doi: 10.1038/s41551-018-0191-4. Epub 2018 Feb 6.
6
Intravenously Delivered Mesenchymal Stem Cells: Systemic Anti-Inflammatory Effects Improve Left Ventricular Dysfunction in Acute Myocardial Infarction and Ischemic Cardiomyopathy.静脉内输注间充质干细胞：全身抗炎作用改善急性心肌梗死和缺血性心肌病的左心室功能障碍。
Circ Res. 2017 May 12;120(10):1598-1613. doi: 10.1161/CIRCRESAHA.117.310599. Epub 2017 Feb 23.
7
Long-Term Survival Among Patients With Myocardial Infarction Before Age 50 Compared With the General Population: A Danish Nationwide Cohort Study.50岁前心肌梗死患者与普通人群的长期生存率：一项丹麦全国队列研究。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):523-31. doi: 10.1161/CIRCOUTCOMES.115.002661. Epub 2016 Aug 30.
8
Stem cell-based therapies to promote angiogenesis in ischemic cardiovascular disease.基于干细胞的疗法促进缺血性心血管疾病中的血管生成。
Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H455-65. doi: 10.1152/ajpheart.00726.2015. Epub 2015 Dec 18.
9
Hurdles to clinical translation of human induced pluripotent stem cells.人类诱导多能干细胞临床转化面临的障碍。
J Clin Invest. 2015 Jul 1;125(7):2551-7. doi: 10.1172/JCI80575.
10
Hypoxic preconditioning of mesenchymal stromal cells induces metabolic changes, enhances survival, and promotes cell retention in vivo.间充质基质细胞的低氧预处理可诱导代谢变化、提高存活率并促进其在体内的细胞留存。
Stem Cells. 2015 Jun;33(6):1818-28. doi: 10.1002/stem.1976. Epub 2015 May 11.
Zotero 插件